| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.67B | 1.68B | 1.74B | 1.68B | 1.92B | 1.97B |
| Gross Profit | 1.14B | 1.15B | 1.19B | 1.06B | 1.12B | 1.32B |
| EBITDA | 280.57M | 351.21M | -655.84M | 46.44M | -1.86B | 2.12B |
| Net Income | 272.49M | 207.00M | -639.36M | 115.00M | -1.78B | 1.81B |
Balance Sheet | ||||||
| Total Assets | 10.25B | 10.04B | 9.74B | 10.58B | 10.49B | 12.64B |
| Cash, Cash Equivalents and Short-Term Investments | 5.50B | 4.70B | 3.83B | 3.97B | 3.86B | 5.38B |
| Total Debt | 44.65M | 47.22M | 38.90M | 57.56M | 232.81M | 216.24M |
| Total Liabilities | 1.04B | 832.42M | 665.80M | 911.38M | 1.13B | 1.10B |
| Stockholders Equity | 10.18B | 9.21B | 9.07B | 9.67B | 9.35B | 11.53B |
Cash Flow | ||||||
| Free Cash Flow | 152.28M | 73.12M | 143.47M | 30.27M | -262.57M | 62.77M |
| Operating Cash Flow | 224.89M | 141.65M | 198.90M | 101.60M | -211.19M | 66.74M |
| Investing Cash Flow | 39.33M | -141.10M | -923.98M | 1.18B | 276.79M | 475.94M |
| Financing Cash Flow | -166.13M | -133.21M | -109.81M | -307.86M | -334.57M | -673.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
83 Outperform | HK$11.02B | 3.36 | 38.33% | 6.92% | 5.77% | 3.95% | |
78 Outperform | HK$4.49B | 7.36 | 10.39% | 8.21% | 3.23% | -21.82% | |
78 Outperform | HK$48.00B | 10.31 | 21.66% | 6.15% | 5.51% | 3.90% | |
78 Outperform | HK$70.83B | 6.02 | 17.82% | 4.31% | 15.93% | 20.70% | |
71 Outperform | HK$17.32B | 10.91 | 14.30% | 5.87% | 14.76% | 23.04% | |
68 Neutral | HK$2.44B | 3.44 | 3.61% | 5.01% | -2.56% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |